enGene Reports Full Year 2023 Financial Results and Recent O

Achieved primary and secondary endpoints in Phase 1 portion of LEGEND study in non-muscle invasive bladder cancer (NIMBC); pivotal portion underway with...

Related Keywords

Canada , Boston , Massachusetts , United States , Montreal , Quebec , Canadian , Alex Nichols , Richard Bryce , Ryan Daws , Lota Zoth , Derivatized Oligochitosan , Jason Hanson , Public Company , Nasdaq , Forbion European Acquisition Corporation , Clinical Program Progress , Company Board Of Directors , Exchange Commission , Forbion European Acquisition Corp , Company Audit Committee Chair , Gene Holdings Inc , Company Annual Report On Form , Gene Holdings , Chief Executive Officer , Chief Financial Officer , Hercules Capital , Business Highlights , Company Launch , Program Progress , Secondary Endpoints , Hercules Capital Debt Facility , Leadership Hires , Chief Operating Officer , Chief Medical Officer , Chief Financial , Audit Committee , Upcoming Anticipated , Annual Meeting , Urologic Oncology , Reverse Recapitalization , Bacillus Calmette Gu , Dually Derivatized Oligochitosan , Private Securities Litigation Reform Act , Annual Report , Consolidated Statements , Ended October ,